The Scientist

» drug development, evolution and immunology

Most Recent

image: Evolution of Fish Bioluminescence

Evolution of Fish Bioluminescence

By | June 9, 2016

Fish evolved to make their own light at least 27 times, according to a study.

1 Comment

The change should allow patients with fatal illnesses easier access to experimental drugs, but gaining permission from drug companies remains the biggest challenge.


A transposon underlies this classic story of evolutionary adaptation.

1 Comment

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Contributors


By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.


image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Scientific progress is only achieved when humans' innate sense of understanding is validated by objective reality.


Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43


image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.


Caltech’s Frances Arnold is honored for her work on directed evolution.

1 Comment

Popular Now

  1. HIV Spread from Haiti to NYC in 1970, “Patient Zero” Not to Blame
  2. Culprit for Antibody Blockade Identified
  3. Investigation Finds Pathologist Guilty of Systemic Misconduct
  4. Many Evolutionary Paths Lead to Same Bird Trait